USE OF QUINOLINE DERIVATIVES IN THE TREATMENT OF PAIN AND IRRITABLE BOWEL SYNDROME
申请人:Bruton Gordon
公开号:US20100041672A1
公开(公告)日:2010-02-18
The use of 5-HT
6
serotonin receptor antagonists of formula (I):
or pharmaceutically acceptable salts thereof, is described for the treatment of Irritable Bowel Syndrome and pain in mammals, more particularly inflammatory, neuropathic or visceral pain.